A detailed history of Endowment Wealth Management, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Endowment Wealth Management, Inc. holds 100,518 shares of HUMA stock, worth $466,403. This represents 0.4% of its overall portfolio holdings.

Number of Shares
100,518
Previous 100,518 -0.0%
Holding current value
$466,403
Previous $482,000 13.28%
% of portfolio
0.4%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$2.87 - $9.1 $8,610 - $27,300
3,000 Added 3.08%
100,518 $482,000
Q2 2023

Aug 10, 2023

BUY
$2.86 - $4.97 $2,574 - $4,473
900 Added 0.93%
97,518 $278,000
Q4 2021

Feb 11, 2022

BUY
$7.25 - $11.6 $700,480 - $1.12 Million
96,618 New
96,618 $700,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $478M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Endowment Wealth Management, Inc. Portfolio

Follow Endowment Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endowment Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endowment Wealth Management, Inc. with notifications on news.